Roche’s Actemra May Curb Deaths in Critical Covid Patients

(Bloomberg) -- Roche Holding AG’s Actemra may help critically ill patients survive Covid-19, according to researchers who used a novel approach to show those who quickly got the anti-inflammatory m...